Sensus Healthcare price target lowered to $6 from $13 at Lake Street

Lake Street lowered the firm’s price target on Sensus Healthcare (SRTS) to $6 from $13 and keeps a Buy rating on the shares. Q2 results fell below expectations and the firm’s conclusion from its survey work that suggested upside to the quarter “was flat-out wrong,” the analyst tells investors. However, the firm still believes “all roads ultimately lead to greater certainty and should benefit Sensus,” the analyst added.